Do you think big pharma would offer a deal commensurate with good results in m/m, assured good results in s/c, an upcoming PDUFA data and multiple indications? I don't think so. Besides COVID-19 distribution is already spoken for. BP deals would not be a positive in the long run.

Deals outside the U.S. would be ok if we got a large percentage.